Clinical Studies
Here, we present the findings of three clinical studies conducted on our products by our renowned third-party laboratory partners in Europe. The products tested include:
AtoArmor Pack: Efficacy on Subjects
Prone to Atopic Dermatitis
Over a 42-day period, adult test subjects in Italy with a predisposition to Atopic Dermatitis used and consumed the entire AtoArmor Pack, consisting of AtoArmor Premium Multivitamin, Ferrina Zinc (formerly known as Skin’Pure), and Active Care Cream. The study was conducted by Complife.
ATOARMOR CLINICAL STUDIES
EFFICACY ON SUBJECTS PRONE TO ATOPIC DERMATITIS
FINAL RESULTS(T0 VS T42)
INSTRUMENTAL EVALUATION – ERYTHEMA INDEX
Variation % vs TO
-13.1%
*p<0.05vsTo
The measurement of skin erythema is carried out by means of MEXAMETER that specifically measures hemoglobin content in the skin by the principle of absorption/reflection
Clinical/Subjective Evaluation (VAS Score)
Percentage of subjects who showed improvement:
- Erythema/Redness: 90%
- Tightness: 70%
- Itching: 70%
Self-assessment of Treatment Efficacy
Complife asked participants to rate the treatment efficacy on atopic dermatitis signs on a scale of 1 to 10. This chart summarizes their evaluations.
Self-assessment of Skin Conditions after 42 Days
This graph illustrates skin condition improvements following 42 days of product use.
Conclusions
After 42 days of using the AtoArmor product line, there was a statistically significant, 13.1% decrease in skin erythema.
The clinical analysis demonstrated reductions in skin redness and itching, as well as significant improvements in all other considered skin signs and symptoms.
Active Care Cream: Suitability and Effects on Children with Atopic Dermatitis
Dermatest, a German laboratory, separately tested our Active Care Cream to evaluate its suitability and effects on children aged 2 to 18 with sensitive skin prone to or diagnosed with Atopic Dermatitis. Participants applied the solution twice daily.
ATOARMOR ACTIVE CARE CREAM CLINICAL STUDY
RESULTS OF CREAM APPLICATION ON CHILDREN WITH ATOPIC DERMATITIS
These photographs taken over 4 weeks demonstrate the tolerability and positive changes in the skin of children diagnosed with Atopic Dermatitis by a dermatologist.
Ferrina Zinc: Efficacy on Acne-Prone Skin
Our powder Lactoferrin and Zinc supplement, Ferrina Zinc (previously SKIN’PURE), was tested in France on subjects with Acne and similar skin imperfections.
A study was conducted on 173 consumers (18% men, 82% women) aged 18 to 36 with skin imperfections. Participants took Ferrina Zinc for 28 days without any other medical or food supplement cure for acne-related skin imperfections.
Consumers graded their imperfections on a scale of 1 to 9 before and after the study. This graph shows overall improvements in skin conditions.
Results on acne-related skin imperfections
Conclusions
Ferrina Zinc represents an efficient and alternative solution to help reduce skin imperfections, with significant changes and improvements perceived after only 28 days of consumption.
AtoArmor Pack: Efficacy on Subjects
Prone to Atopic Dermatitis
Over a 42-day period, adult test subjects in Italy with a predisposition to Atopic Dermatitis used and consumed the entire AtoArmor Pack, consisting of AtoArmor Premium Multivitamin, Ferrina Zinc (formerly known as Skin’Pure), and Active Care Cream. The study was conducted by Complife.
ATOARMOR CLINICAL STUDIES
EFFICACY ON SUBJECTS PRONE TO ATOPIC DERMATITIS
FINAL RESULTS(T0 VS T42)
INSTRUMENTAL EVALUATION – ERYTHEMA INDEX
Variation % vs TO
-13.1%
*p<0.05vsTo
The measurement of skin erythema is carried out by means of MEXAMETER that specifically measures hemoglobin content in the skin by the principle of absorption/reflection
Clinical/Subjective Evaluation (VAS Score)
Percentage of subjects who showed improvement:
- Erythema/Redness: 90%
- Tightness: 70%
- Itching: 70%
Self-assessment of Treatment Efficacy
Complife asked participants to rate the treatment efficacy on atopic dermatitis signs on a scale of 1 to 10. This chart summarizes their evaluations.
Self-assessment of Skin Conditions after 42 Days
This graph illustrates skin condition improvements following 42 days of product use.
Conclusions
After 42 days of using the AtoArmor product line, there was a statistically significant, 13.1% decrease in skin erythema.
The clinical analysis demonstrated reductions in skin redness and itching, as well as significant improvements in all other considered skin signs and symptoms.
Active Care Cream: Suitability and Effects on Children with Atopic Dermatitis
Dermatest, a German laboratory, separately tested our Active Care Cream to evaluate its suitability and effects on children aged 2 to 18 with sensitive skin prone to or diagnosed with Atopic Dermatitis. Participants applied the solution twice daily.
ATOARMOR ACTIVE CARE CREAM CLINICAL STUDY
RESULTS OF CREAM APPLICATION ON CHILDREN WITH ATOPIC DERMATITIS
These photographs taken over 4 weeks demonstrate the tolerability and positive changes in the skin of children diagnosed with Atopic Dermatitis by a dermatologist.
Ferrina Zinc: Efficacy on Acne-Prone Skin
Our powder Lactoferrin and Zinc supplement, Ferrina Zinc (previously SKIN’PURE), was tested in France on subjects with Acne and similar skin imperfections.
A study was conducted on 173 consumers (18% men, 82% women) aged 18 to 36 with skin imperfections. Participants took Ferrina Zinc for 28 days without any other medical or food supplement cure for acne-related skin imperfections.
Consumers graded their imperfections on a scale of 1 to 9 before and after the study. This graph shows overall improvements in skin conditions.
Results on acne-related skin imperfections
Conclusions
Ferrina Zinc represents an efficient and alternative solution to help reduce skin imperfections, with significant changes and improvements perceived after only 28 days of consumption.